Skip to main content

Clinical and Translational Oncology

Ausgabe 11/2023

Inhalt (22 Artikel)

REVIEW ARTICLE

Unveiling the vulnerabilities of synthetic lethality in triple-negative breast cancer

Prarthana Chatterjee, Rohit Karn, Arnold Emerson Isaac, Smita Ray

REVIEW ARTICLE

Cardiovascular toxicity of checkpoint inhibitors: review of associated toxicity and design of the Spanish Immunotherapy Registry of Cardiovascular Toxicity

Eduardo Zatarain-Nicolás, Pilar Martín, Iván Márquez Rodas, Juan Virizuela, Ana Martín García, Cristina Mitroi, Juan Cosín Sales, Vivencio Barrios, Fátima Sánchez-Cabo, Borja Ibañez, Javier de Castro Carpeño, Teresa López Fernández

Open Access REVIEW ARTICLE

Adverse events of antibody–drug conjugates on the ocular surface in cancer therapy

Sandra Domínguez-Llamas, Manuel Caro-Magdaleno, Beatriz Mataix-Albert, Javier Avilés-Prieto, Isabel Romero-Barranca, Enrique Rodríguez-de-la-Rúa

REVIEW ARTICLE

Circular RNAs-mediated angiogenesis in human cancers

Farhoodeh Ghaedrahmati, Ava Nasrolahi, Sajad Najafi, Mohammad Mighani, Omid Anbiyaee, Habib Haybar, Ahmad Reza Assareh, Bartosz Kempisty, Piotr Dzięgiel, Shirin Azizidoost, Maryam Farzaneh

Open Access SPECIAL ARTICLE

Expert consensus to optimize the management of older adult patients with advanced EGFR-mutated non-small cell lung cancer

Ernest Nadal, Martín Oré-Arce, Jordi Remon, Reyes Bernabé-Caro, Marta Covela-Rúa, Javier de Castro-Carpeño, Bartomeu Massutí-Sureda, Mónica Guillot-Morales, Margarita Majem, Inmaculada Maestu-Maiques, Idoia Morilla-Ruíz, Regina Gironés

RESEARCH ARTICLE

Induction of perineural invasion in salivary adenoid cystic carcinoma by circular RNA RNF111

RongBin Su, ShuSheng Zhong, PengHui Wang, ZhongWei Lin

Open Access RESEARCH ARTICLE

Radioprotective potential of probiotics against gastrointestinal and neuronal toxicity: a preclinical study

Babu Santhi Venkidesh, Saligrama R Shankar, Rekha Koravadi Narasimhamurthy, Satish Bola Sadashiva Rao, Kamalesh Dattaram Mumbrekar

Open Access RESEARCH ARTICLE

Dipeptidyl peptidase 4 inhibitor reduces tumor-associated macrophages and enhances anti-PD-L1-mediated tumor suppression in non-small cell lung cancer

Bei Zuo, Tao Li, Xiaoyun Liu, Shuling Wang, Jianxiang Cheng, Xiangqun Liu, Wenjie Cui, Hengliang Shi, Chunhua Ling

RESEARCH ARTICLE

LncRNA OTUD6B-AS1 overexpression promoted GPX4-mediated ferroptosis to suppress radioresistance in colorectal cancer

Zilang Zhang, Baolong Ye, Yiban Lin, Wenjun Liu, Jianzhong Deng, Wu Ji

RESEARCH ARTICLE

Automated treatment planning for liver cancer stereotactic body radiotherapy

Ling He, Xingchen Peng, Na Chen, Zhigong Wei, Jingjing Wang, Yingtong Liu, Jianghong Xiao

RESEARCH ARTICLE

MTF1 has the potential as a diagnostic and prognostic marker for gastric cancer and is associated with good prognosis

Jin He, Xianglai Jiang, Miao Yu, Pingan Wang, Liangyin Fu, Guangming Zhang, Hui Cai

RESEARCH ARTICLE

Hsa_circ_0102899 promotes epithelial–mesenchymal transition in non-small cell lung cancer

YanFei Wang, JieMing He, YongXue Liang, DaLin Xiong

RESEARCH ARTICLE

AKAP12 promotes cancer stem cell-like phenotypes and activates STAT3 in colorectal cancer

Ke Li, Xuan Wu, Yuan Li, Ting-Ting Hu, Weifeng Wang, Frank J. Gonzalez, Weiwei Liu

RESEARCH ARTICLE

Cervical carcinoma induces NLRP3 inflammasome activation and IL-1ß release in human peripheral blood monocytes affecting patients’ overall survival

Fernanda Pereira Fernandes, Raylane Adrielle Gonçalves Cambui, Jaíne Lima da Silva Soares, Edione Cristina dos Reis, Vinícius Nunes Cordeiro Leal, Alessandra Pontillo

RESEARCH ARTICLE

Role of microsatellite instability and HER2 positivity in locally advanced esophago-gastric cancer patients treated with peri-operative chemotherapy

Lorenzo Gervaso, Luca Bottiglieri, Monica Isabel Meneses-Medina, Stefania Pellicori, Roberto Biffi, Uberto Fumagalli Romario, Stefano De Pascale, Isabella Sala, Vincenzo Bagnardi, Massimo Barberis, Chiara Alessandra Cella, Nicola Fazio

RESEARCH ARTICLE

A nine-gene signature as prognostic biomarker in gastric cancer by bioinformatics analysis

Guan Wang, Zhijian Ren, Yang Zhao, Yumin Li

BRIEF RESEARCH ARTICLE

Therapeutic strategies and clinical evolution of patients with infantile fibrosarcoma: a unique paediatric case series

María Dolores Corral Sánchez, Raquel Jiménez Carrascoso, Pedro Rubio Aparicio, Diego Plaza López de Sabando, Ana Sastre Urgelles, José Juan Pozo-Kreilinger, Juan Carlos López Gutiérrez, Manuel Gómez Cervantes, Eduardo José Ortiz Cruz, Antonio Pérez-Martínez

BRIEF RESEARCH ARTICLE

Making Radiation Oncology specialty more attractive to young medical graduates: pulling back the invisibility curtain

Elías Gomis Sellés, Angel Montero, Meritxell Arenas

CORRESPONDENCE

Just medical oncology guidelines…

Ricardo Pardo García, Antonio Piñero Madrona, Manel Algara López, Laia Bernet Vegué, Arantxa Eraso Urien

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.